What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cytokine
- Immune system
Pierre Miossec mainly focuses on Immunology, Interleukin 17, Rheumatoid arthritis, Inflammation and Arthritis.
Immunology is closely attributed to Cancer research in his work.
His research in Interleukin 17 intersects with topics in Proinflammatory cytokine, Psoriasis, Autoimmunity and Synovial membrane.
The various areas that Pierre Miossec examines in his Rheumatoid arthritis study include Autoimmune disease and Pathogenesis, Pathology.
His Inflammation study incorporates themes from Receptor, T helper cell and Immune system, Immunotherapy.
The concepts of his Cytokine study are interwoven with issues in Molecular biology and Psoriatic arthritis.
His most cited work include:
- Interleukin-17 and type 17 helper T cells. (1079 citations)
- Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. (883 citations)
- Targeting IL-17 and TH17 cells in chronic inflammation. (748 citations)
What are the main themes of his work throughout his whole career to date?
Pierre Miossec spends much of his time researching Immunology, Rheumatoid arthritis, Interleukin 17, Inflammation and Tumor necrosis factor alpha.
His is doing research in Cytokine, Proinflammatory cytokine, T cell, Interleukin and Immune system, both of which are found in Immunology.
His work carried out in the field of Rheumatoid arthritis brings together such families of science as Infliximab, Disease and Arthritis.
His Interleukin 17 research incorporates elements of Psoriasis, Psoriatic arthritis, Bone resorption, Chemokine and Ankylosing spondylitis.
His Inflammation study integrates concerns from other disciplines, such as Receptor and Pathogenesis.
The study incorporates disciplines such as Cancer research, RUNX2, Gene expression, Interleukin 6 and Bone morphogenetic protein 2 in addition to Tumor necrosis factor alpha.
He most often published in these fields:
- Immunology (55.78%)
- Rheumatoid arthritis (41.71%)
- Interleukin 17 (27.64%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (55.78%)
- Inflammation (27.14%)
- Rheumatoid arthritis (41.71%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immunology, Inflammation, Rheumatoid arthritis, Interleukin 17 and Tumor necrosis factor alpha.
His work in the fields of Immunology, such as Cytokine, Interleukin, Proinflammatory cytokine and T cell, overlaps with other areas such as Cytokine storm.
His study with Inflammation involves better knowledge in Internal medicine.
His work deals with themes such as Clinical research, Infliximab, Disease and Arthritis, which intersect with Rheumatoid arthritis.
Pierre Miossec combines subjects such as Psoriatic arthritis, Thrombosis, Ankylosing spondylitis and Pathogenesis with his study of Interleukin 17.
His Tumor necrosis factor alpha research includes elements of Interleukin 6, Molecular biology, Immune system and Tuberculosis.
Between 2015 and 2021, his most popular works were:
- IL-17 in Chronic Inflammation: From Discovery to Targeting (210 citations)
- Selected cytokine pathways in rheumatoid arthritis. (104 citations)
- Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. (84 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cytokine
- Immune system
Immunology, Interleukin 17, Cytokine, Inflammation and Rheumatoid arthritis are his primary areas of study.
His Immunology study focuses mostly on Interleukin, Pathogenesis, Ankylosing spondylitis and Arthritis.
His Cytokine research is multidisciplinary, incorporating elements of Psoriasis, Psoriatic arthritis, Podoplanin, Peripheral blood mononuclear cell and CD3.
Pierre Miossec has researched Peripheral blood mononuclear cell in several fields, including Secretion, T cell, T-cell receptor, Molecular biology and Antibody.
His Inflammation study which covers Tumor necrosis factor alpha that intersects with RUNX2, Proinflammatory cytokine, Cause of death and Thrombosis.
His studies deal with areas such as Regulation of gene expression and Disease as well as Rheumatoid arthritis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
